BiotechTube
Home/Gero/Peter Fedichev, PhD
PF

Peter Fedichev, PhD

CEO, Co‑Founder

Gero

Therapeutic Areas

AgingFibrosisNeurodegeneration

Gero Pipeline

DrugIndicationPhase
ProtoBind‑Diff Antibody CandidatesSystemic Aging / ResiliencePreclinical
Fibrosis Target ProgramFibrotic DiseasesPreclinical
Chugai Co‑Development AntibodyAge‑Related Immune DysfunctionPreclinical

Leadership Team at Gero

MK
Maxim Kholin
Chief Corporate Development Officer, Co‑Founder
AS
Aleksandr Sviridov
Chief Operating Officer
BK
Brian Kennedy, PhD
Independent Director, Board Member
YM
Yuri Melnichek
Board Member
VG
Vadim Gladyshev, PhD
Scientific Advisor
View full Gero profile